Showing results (801-810 of 813) with videos related to
Sort By:
Pageof 82
Nature Aging|May 12, 2026
Hypoxia-induced autophagic degradation of HIF-1α attenuates cellular aging and extends mammalian lifespanChen Yang, Zeng Xu, Sha-Tong He, et al.Frontiers in Physiology|April 8, 2020
Cardiovascular Remodeling Experienced by Real-World, Unsupervised, Young Novice Marathon RunnersAndrew D'Silva, Anish N Bhuva, Jet van Zalen, et al.Signal Transduction and Targeted Therapy|September 15, 2025
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trialZhan Wang, Bao-Dong Qin, Chen-Yang Ye, et al.ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)Jun Li, Lawrence J Kennedy, Steven J Walker, et al.Journal of Medicinal Chemistry|September 7, 2021
Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor to Overcome C797S-Mediated ResistanceM Raymond V Finlay, Peter Barton, Sue Bickerton, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 16, 2022
Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Küster-Hauser syndromeCongcong Ma, Na Chen, Angad Jolly, et al.Journal of Medicinal Chemistry|September 19, 2023
Discovery of <b>12</b> (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic DisordersWei Meng, Robert Brigance, James Mignone, et al.Science Translational Medicine|April 24, 2020
Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and ratsYaohui Wang, Hailong Zhang, Zhizeng Wang, et al.Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.Pageof 82